Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. [electronic resource]
Producer: 20130820Description: 511-6 p. digitalISSN:- 1523-1755
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antigens, CD19 -- analysis
- Antigens, CD20 -- immunology
- Female
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Nephrosis, Lipoid -- drug therapy
- Prednisone -- therapeutic use
- Recurrence
- Retrospective Studies
- Rituximab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.